Skip to Main Content

Author Details

Sarfraz Memon
Center for Cancer Research, National Cancer Institute.
1988
23
16
PMIDPaper TitleJournal TitlePublished Year
34875023Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosus.Rheumatology (Oxford)2022
34875023Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosus.Rheumatology (Oxford)2022
27694491Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease.J Immunol2016
27694491Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease.J Immunol2016
26697911The Biobank Economic Modeling Tool (BEMT): Online Financial Planning to Facilitate Biobank Sustainability.Biopreserv Biobank2015
26697911The Biobank Economic Modeling Tool (BEMT): Online Financial Planning to Facilitate Biobank Sustainability.Biopreserv Biobank2015
21986106Quantitative analysis of T cell receptor diversity in clinical samples of human peripheral blood.J Immunol Methods2012
22289893Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation.Blood2012
21986106Quantitative analysis of T cell receptor diversity in clinical samples of human peripheral blood.J Immunol Methods2012
22289893Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation.Blood2012
21421838Evolution of the donor T-cell repertoire in recipients in the second decade after allogeneic stem cell transplantation.Blood2011
21421838Evolution of the donor T-cell repertoire in recipients in the second decade after allogeneic stem cell transplantation.Blood2011
18275895Up-regulation of NK cell activating receptors following allogeneic hematopoietic stem cell transplantation under a lymphodepleting reduced intensity regimen is associated with elevated IL-15 levels.Biol Blood Marrow Transplant2008
18573906Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets.J Exp Med2008
18275895Up-regulation of NK cell activating receptors following allogeneic hematopoietic stem cell transplantation under a lymphodepleting reduced intensity regimen is associated with elevated IL-15 levels.Biol Blood Marrow Transplant2008
18573906Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets.J Exp Med2008
15738052Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.J Exp Med2005
15776111Age-dependent incidence, time course, and consequences of thymic renewal in adults.J Clin Invest2005
15935806Lymphocyte toxicity and T cell receptor excision circles in workers exposed to benzene.Chem Biol Interact2005
15738052Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.J Exp Med2005
15935806Lymphocyte toxicity and T cell receptor excision circles in workers exposed to benzene.Chem Biol Interact2005
15776111Age-dependent incidence, time course, and consequences of thymic renewal in adults.J Clin Invest2005
15130942Exogenous IL-7 increases recent thymic emigrants in peripheral lymphoid tissue without enhanced thymic function.Blood2004
15130942Exogenous IL-7 increases recent thymic emigrants in peripheral lymphoid tissue without enhanced thymic function.Blood2004
9498739Apoptosis induced by a chimeric Fas/FLICE receptor: lack of requirement for Fas- or FADD-binding proteins.J Immunol1998
9498739Apoptosis induced by a chimeric Fas/FLICE receptor: lack of requirement for Fas- or FADD-binding proteins.J Immunol1998
8892614Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity.J Immunol1996
8892614Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity.J Immunol1996
7594463Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T cell hybridoma.J Immunol1995
7594463Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T cell hybridoma.J Immunol1995
7897244A simple assay for examining the effect of transiently expressed genes on programmed cell death.J Immunol Methods1995
7897244A simple assay for examining the effect of transiently expressed genes on programmed cell death.J Immunol Methods1995
8157859Effects of high sugar diets on renal fluid, electrolyte and mineral handling in rats: relationship to blood pressure.J Am Coll Nutr1994
8157859Effects of high sugar diets on renal fluid, electrolyte and mineral handling in rats: relationship to blood pressure.J Am Coll Nutr1994
8051409Dominant negative mutant of c-Jun inhibits NF-AT transcriptional activity and prevents IL-2 gene transcription.J Immunol1994
8051409Dominant negative mutant of c-Jun inhibits NF-AT transcriptional activity and prevents IL-2 gene transcription.J Immunol1994
8462264Important aspects concerning evaluation of renal function and blood pressure. Kinins, prostaglandins, lead.Clin Lab Med1993
8483244Rabbit and human renotropin are not epidermal growth factor.J Urol1993
8462264Important aspects concerning evaluation of renal function and blood pressure. Kinins, prostaglandins, lead.Clin Lab Med1993
8483244Rabbit and human renotropin are not epidermal growth factor.J Urol1993
2846612Antibody reactivity with HBLV (HHV-6) in U.S. populations.J Virol Methods1988
2846617Human B-lymphotropic virus (human herpesvirus-6).J Virol Methods1988
3182953Molecular studies of HHV-6.J Virol Methods1988
2846612Antibody reactivity with HBLV (HHV-6) in U.S. populations.J Virol Methods1988
2846617Human B-lymphotropic virus (human herpesvirus-6).J Virol Methods1988
3182953Molecular studies of HHV-6.J Virol Methods1988
  • 1 - 46 of 46

Recommended Authors

Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2000
Number of shared co-authors 0
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1998
Number of shared co-authors 0
Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham
Career Start Year 1993
Number of shared co-authors 0
Duke University School of Medicine
Career Start Year 1992
Number of shared co-authors 0
Universite de Montreal
Career Start Year 1991
Number of shared co-authors 1
Heidelberg University
Career Start Year 1990
Number of shared co-authors 0
Helen Wills Neuroscience Institute, University of California berkeley
Career Start Year 1988
Number of shared co-authors 0
Merck & Co. Inc.
Career Start Year 1987
Number of shared co-authors 0
University of California Los Angeles
Career Start Year 1986
Number of shared co-authors 0
University of Cambridge Clinical School, LIFNanoRx Ltd
Career Start Year 1984
Number of shared co-authors 0
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 0
Pathology Advanced Translational Research Unit, Emory University School of Medicine
Career Start Year 1981
Number of shared co-authors 2
University of Nebraska Medical Center
Career Start Year 1980
Number of shared co-authors 0
St. Anna Children's Hospital, Medical University of Vienna
Career Start Year 1980
Number of shared co-authors 0
Center for Computational and Integrative Biology, Massachusetts General Hospital
Career Start Year 1980
Number of shared co-authors 0
Cambridge University Hospitals NHS Foundation
Career Start Year 1979
Number of shared co-authors 0
8Benaroya Research Institute
Career Start Year 1978
Number of shared co-authors 1
University of Alabama at Birmingham and Birmingham VA Medical Center.
Career Start Year 1978
Number of shared co-authors 0
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 1977
Number of shared co-authors 0
Medical University of Innsbruck
Career Start Year 1976
Number of shared co-authors 1
BioKien LLC
Career Start Year 1976
Number of shared co-authors 0
Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital
Career Start Year 1976
Number of shared co-authors 4
Center for Cancer Research, National Cancer Institute
Career Start Year 1975
Number of shared co-authors 6
Massachusetts General Hospital
Career Start Year 1973
Number of shared co-authors 0
Gladstone Institute of Virology, USA University of California san francisco
Career Start Year 1971
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1970
Number of shared co-authors 2
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1970
Number of shared co-authors 0
RIKEN Center for Integrative Medical Sciences (IMS)
Career Start Year 1966
Number of shared co-authors 0
University of British Columbia
Career Start Year 1965
Number of shared co-authors 1
Monash University
Career Start Year 1958
Number of shared co-authors 0

Collaborators

National Cancer Institute
Co-authored papers 11
National Cancer Institute, National Institutes of Health
Co-authored papers 9
National Cancer Institute
Co-authored papers 3
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Co-authored papers 1
National Cancer Institute, National Institutes of Health
Co-authored papers 1
University of Nebraska Medical Center (UNMC)
Co-authored papers 1
Center for Cellular Engineering, NIH Clinical Center, National Institutes of Health
Co-authored papers 1
Co-authored papers 1
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Clinical Center, National Institutes of Health
Co-authored papers 1
National Institute of Dental and Craniofacial Research, National Institutes of Health
Co-authored papers 1
University of Pennsylvania Department of Pathology & Laboratory Medicine
Co-authored papers 1
Co-authored papers 1
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Co-authored papers 1
Clinical Center, National Institutes of Health
Co-authored papers 1
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Cincinnati Children's Hospital Medical Center
Co-authored papers 1
Co-authored papers 1
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers 1
National Cancer Institute
Co-authored papers 1
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 1
National Institute of Dental and Craniofacial Research
Co-authored papers 1
Rutgers Robert Wood Johnson Medical School
Co-authored papers 1
Co-authored papers 1